Brief: Brainsway Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep Tms™ For Depression
June 10 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY LAUNCHES PROSPECTIVE, RANDOMIZED, CONTROLLED,
MULTICENTER TRIAL EVALUATING ACCELERATED DEEP TMS™ FOR
DEPRESSION
* BRAINSWAY LTD: CLINICAL TRIAL IS ANTICIPATED TO ENROLL
OVER 100
PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Source text for Eikon: ID:nGNX3Pg2Yh
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)